Business Context and Reporting Period
PDS Biotechnology Corporation (PDSB), a Delaware corporation, filed this Form 8-K on June 15, 2026. The filing announces the scheduling of the Company's 2026 Annual Meeting of Stockholders.
Financial Metrics
This filing does not contain financial data. No information regarding revenue, profit, cash flow, margins, debt, or liquidity is provided in this document.
Material Changes
The filing reports no material changes to financial performance or operations. The primary event is the administrative scheduling of the upcoming Annual Meeting.
Guidance, Outlook, and Management Commentary
The Board of Directors has scheduled the 2026 Annual Meeting for August 10, 2026. Because this date is more than 30 days from the anniversary of the 2025 Annual Meeting, the Company has established a deadline of June 25, 2026, for the submission of stockholder proposals under Rule 14a-8. Proposals must be sent to the Corporate Secretary at the Company's principal executive offices in Princeton, NJ. Further details will be included in the Definitive Proxy Statement on Schedule 14A.
Key Facts for Investors to Verify
- 2026 Annual Meeting Date: August 10, 2026.
- Stockholder Proposal Deadline: June 25, 2026.
- Submission Address: PDS Biotechnology Corporation, 303A College Road East, Princeton, NJ 08540, Attention: Corporate Secretary.
- Future Filing: Definitive Proxy Statement (Schedule 14A) to be filed with the SEC.